184 related articles for article (PubMed ID: 22387047)
1. Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.
Liu X; Guo W; Wu S; Wang L; Wang J; Dai B; Kim ES; Heymach JV; Wang M; Girard L; Minna J; Roth JA; Swisher SG; Fang B
Biochem Pharmacol; 2012 May; 83(10):1456-64. PubMed ID: 22387047
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition.
Guo W; Wu S; Wang L; Wei X; Liu X; Wang J; Lu Z; Hollingshead M; Fang B
PLoS One; 2011; 6(12):e28487. PubMed ID: 22174819
[TBL] [Abstract][Full Text] [Related]
3. Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
Li L; Chen M; Li G; Cai R
Tissue Cell; 2021 Aug; 71():101577. PubMed ID: 34146943
[TBL] [Abstract][Full Text] [Related]
4. Fraxetin Suppresses Proliferation of Non-Small-Cell Lung Cancer Cells via Preventing Activation of Signal Transducer and Activator of Transcription 3.
Zhang Y; Wang L; Deng Y; Zhao P; Deng W; Zhang J; Luo J; Li R
Tohoku J Exp Med; 2019 May; 248(1):3-12. PubMed ID: 31080186
[TBL] [Abstract][Full Text] [Related]
5. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance.
Zheng Q; Dong H; Mo J; Zhang Y; Huang J; Ouyang S; Shi S; Zhu K; Qu X; Hu W; Liu P; Wang Y; Zhang X
Theranostics; 2021; 11(2):824-840. PubMed ID: 33391507
[TBL] [Abstract][Full Text] [Related]
6. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
7. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in NSC-741909-induced apoptosis of cancer cells.
Wei X; Guo W; Wu S; Wang L; Huang P; Liu J; Fang B
J Transl Med; 2010 Apr; 8():37. PubMed ID: 20398386
[TBL] [Abstract][Full Text] [Related]
9. Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer.
Zhao Z; Wang Y; Gong Y; Wang X; Zhang L; Zhao H; Li J; Zhu J; Huang X; Zhao C; Yang L; Wang L
J Transl Med; 2022 Nov; 20(1):525. PubMed ID: 36371217
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells.
Chiu HC; Chou DL; Huang CT; Lin WH; Lien TW; Yen KJ; Hsu JT
Biochem Pharmacol; 2011 Jun; 81(11):1263-70. PubMed ID: 21406185
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3.
Oh SB; Hwang CJ; Song SY; Jung YY; Yun HM; Sok CH; Sung HC; Yi JM; Park DH; Ham YW; Han SB; Hwang BY; Hong JT
Cancer Lett; 2014 Oct; 353(1):95-103. PubMed ID: 25083589
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer.
Wang CY; Chao TT; Tai WT; Chang FY; Su WP; Chen YL; Chen PT; Weng CY; Yuan A; Shiau CW; Yu CJ; Chen KF
J Thorac Oncol; 2014 Apr; 9(4):488-96. PubMed ID: 24736071
[TBL] [Abstract][Full Text] [Related]
13. HJC0152 suppresses human non-small-cell lung cancer by inhibiting STAT3 and modulating metabolism.
Lu L; Li H; Wu X; Rao J; Zhou J; Fan S; Shen Q
Cell Prolif; 2020 Mar; 53(3):e12777. PubMed ID: 32022328
[TBL] [Abstract][Full Text] [Related]
14. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
15. A natural xanthone suppresses lung cancer growth and metastasis by targeting STAT3 and FAK signaling pathways.
Zhao Y; Zhang X; Li Y; Li Y; Zhang H; Song Z; Xu J; Guo Y
Phytomedicine; 2022 Jul; 102():154118. PubMed ID: 35576741
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
Shou J; You L; Yao J; Xie J; Jing J; Jing Z; Jiang L; Sui X; Pan H; Han W
Cancer Lett; 2016 Aug; 379(1):124-33. PubMed ID: 27264264
[TBL] [Abstract][Full Text] [Related]
17. Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Phan AN; Hua TN; Kim MK; Vo VT; Choi JW; Kim HW; Rho JK; Kim KW; Jeong Y
Oncotarget; 2016 Aug; 7(34):54702-54713. PubMed ID: 27419630
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by morusin in human non-small cell lung cancer cells by suppression of EGFR/STAT3 activation.
Park HJ; Min TR; Chi GY; Choi YH; Park SH
Biochem Biophys Res Commun; 2018 Oct; 505(1):194-200. PubMed ID: 30243717
[TBL] [Abstract][Full Text] [Related]
19. Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation.
Leung EL; Fan XX; Wong MP; Jiang ZH; Liu ZQ; Yao XJ; Lu LL; Zhou YL; Yau LF; Tin VP; Liu L
Antioxid Redox Signal; 2016 Feb; 24(5):263-79. PubMed ID: 26528827
[TBL] [Abstract][Full Text] [Related]
20. Induction of autophagy by an oleanolic acid derivative, SZC017, promotes ROS-dependent apoptosis through Akt and JAK2/STAT3 signaling pathway in human lung cancer cells.
Song Y; Kong L; Sun B; Gao L; Chu P; Ahsan A; Qaed E; Lin Y; Peng J; Ma X; Zhang J; Wang S; Tang Z
Cell Biol Int; 2017 Dec; 41(12):1367-1378. PubMed ID: 28880428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
